Beck Bode, LLC Moderna, Inc. Transaction History

Beck Bode, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$118.38 - $210.04 $467,245 - $829,027	-3,947 Reduced 68.18%	1,842 $330,000
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $13,223 - $21,748	-112 Reduced 1.9%	5,789 $685,000
Q2 2022 Jul 29, 2022	BUY	$117.13 - $176.59 $59,853 - $90,237	511 Added 9.48%	5,901 $843,000
Q1 2022 May 02, 2022	BUY	$126.46 - $235.05 $681,619 - $1.27 Million	5,390 New	5,390 $928,000
Q3 2021 Oct 22, 2021	SELL	$221.9 - $484.47 $45,711 - $99,800	-206 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$129.91 - $234.98 $26,761 - $48,405	206 New	206 $48,000
Q1 2021 May 10, 2021	SELL	$109.18 - $185.98 $10,918 - $18,598	-100 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $5,434 - $9,485	100 New	100 $7,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.